Home > Boards > US Listed > Biotechs > Regeneron Pharmaceuticals (REGN)

$REGN - Regeneron: The Amazon Of Biotech?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 540
Posts 24,538
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 5:21:45 PM
Regeneron Says Early-Stage Results Positive for REGN1979 in Lymphoma Dow Jones News - 6/14/2019 7:56:00 AM
Regeneron CD20xCD3 Bispecific REGN1979 Shows Positive Results in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymp... PR Newswire (US) - 6/14/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:19:22 PM
Regeneron Announces Upcoming Investor Conference Presentation PR Newswire (US) - 5/23/2019 9:30:00 AM
Updated Libtayo® (cemiplimab-rwlc) Results Reinforce Durable and Substantial Response Rates in Advanced Cutaneous Squamous C... PR Newswire (US) - 5/16/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/15/2019 4:05:42 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/14/2019 10:47:54 AM
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy PR Newswire (US) - 5/13/2019 4:19:00 PM
Regeneron Says FDA Approves Eylea Injection for All Diabetic Retinopathy Treatment Dow Jones News - 5/13/2019 3:29:00 PM
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy PR Newswire (US) - 5/13/2019 2:45:00 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/9/2019 4:52:51 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/7/2019 5:01:44 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/7/2019 2:06:39 PM
EU Approves Sanofi and Regeneron's Dupixent for Severe Asthma Dow Jones News - 5/7/2019 9:39:00 AM
Dupixent® (dupilumab) Approved for Severe Asthma by European Commission PR Newswire (US) - 5/7/2019 8:59:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 7:51:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 7:36:18 AM
Regeneron's Expense Growth Weighs on Operating Income Dow Jones News - 5/7/2019 7:13:00 AM
Regeneron Reports First Quarter 2019 Financial and Operating Results PR Newswire (US) - 5/7/2019 6:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2019 4:03:08 PM
Regeneron Announces Upcoming Investor Conference Presentations PR Newswire (US) - 4/29/2019 4:01:00 PM
FDA Approves Expanded Label for Praluent Dow Jones News - 4/26/2019 8:29:00 PM
FDA Approves Praluent® (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization PR Newswire (US) - 4/26/2019 7:19:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/26/2019 4:20:32 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist